Learn more about the similarities and difference between biosimilars and reference products and how to integrate biosimilars into your practice.
Learn innovative strategies for psoriasis care with telemedicine.
Through a robust Delphi process, IPC’s network of experts developed a consensus statement that redefines the criteria for patients who are candidates for systemic therapy.
Navigate the landscape of psoriasis in individuals with diverse skin types, understanding its distinct presentation and addressing challenges in access to care, diagnosis, and treatment.
A clinical education tool to help with accurately diagnosing and assessing psoriasis in people with darker skin can be challenging, as many dermatology references often fail to capture the full range of presentations in diverse skin types.
Detect the nuances of GPP, recognize its symptoms, and uncover treatment options.
A compilation of evidence-based guidelines for psoriasis diagnosis and management.
Learn about infectious diseases and their impact on psoriasis care.
Biblioteca de todos los artículos, informes de congresos, publicaciones y videos del IPC disponibles en español publicados en los últimos dos años.
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.
